Live-long Medicine Market
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Live-long Medicine Market Size Growth Rate by Type: 2017 VS 2021 VS 2028
1.2.2 Chinese Herbal Medicine
1.2.3 Western Medicine
1.3 Market by Application
1.3.1 Global Live-long Medicine Market Share by Application: 2017 VS 2021 VS 2028
1.3.2 Young People
1.3.3 Middle-aged People
1.3.4 Old People
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Live-long Medicine Market Perspective (2017-2028)
2.2 Live-long Medicine Growth Trends by Region
2.2.1 Live-long Medicine Market Size by Region: 2017 VS 2021 VS 2028
2.2.2 Live-long Medicine Historic Market Size by Region (2017-2022)
2.2.3 Live-long Medicine Forecasted Market Size by Region (2023-2028)
2.3 Live-long Medicine Market Dynamics
2.3.1 Live-long Medicine Industry Trends
2.3.2 Live-long Medicine Market Drivers
2.3.3 Live-long Medicine Market Challenges
2.3.4 Live-long Medicine Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Live-long Medicine Players by Revenue
3.1.1 Global Top Live-long Medicine Players by Revenue (2017-2022)
3.1.2 Global Live-long Medicine Revenue Market Share by Players (2017-2022)
3.2 Global Live-long Medicine Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Live-long Medicine Revenue
3.4 Global Live-long Medicine Market Concentration Ratio
3.4.1 Global Live-long Medicine Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Live-long Medicine Revenue in 2021
3.5 Live-long Medicine Key Players Head office and Area Served
3.6 Key Players Live-long Medicine Product Solution and Service
3.7 Date of Enter into Live-long Medicine Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Live-long Medicine Breakdown Data by Type
4.1 Global Live-long Medicine Historic Market Size by Type (2017-2022)
4.2 Global Live-long Medicine Forecasted Market Size by Type (2023-2028)
5 Live-long Medicine Breakdown Data by Application
5.1 Global Live-long Medicine Historic Market Size by Application (2017-2022)
5.2 Global Live-long Medicine Forecasted Market Size by Application (2023-2028)
6 North America
6.1 North America Live-long Medicine Market Size (2017-2028)
6.2 North America Live-long Medicine Market Size by Country (2017-2022)
6.3 North America Live-long Medicine Market Size by Country (2023-2028)
6.4 United States
6.5 Canada
7 Europe
7.1 Europe Live-long Medicine Market Size (2017-2028)
7.2 Europe Live-long Medicine Market Size by Country (2017-2022)
7.3 Europe Live-long Medicine Market Size by Country (2023-2028)
7.4 Germany
7.5 France
7.6 U.K.
7.7 Italy
7.8 Russia
7.9 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Live-long Medicine Market Size (2017-2028)
8.2 Asia-Pacific Live-long Medicine Market Size by Country (2017-2022)
8.3 Asia-Pacific Live-long Medicine Market Size by Country (2023-2028)
8.4 China
8.5 Japan
8.6 South Korea
8.7 Southeast Asia
8.8 India
8.9 Australia
9 Latin America
9.1 Latin America Live-long Medicine Market Size (2017-2028)
9.2 Latin America Live-long Medicine Market Size by Country (2017-2022)
9.3 Latin America Live-long Medicine Market Size by Country (2023-2028)
9.4 Mexico
9.5 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Live-long Medicine Market Size (2017-2028)
10.2 Middle East & Africa Live-long Medicine Market Size by Country (2017-2022)
10.3 Middle East & Africa Live-long Medicine Market Size by Country (2023-2028)
10.4 Turkey
10.5 Saudi Arabia
10.6 UAE
11 Key Players Profiles
11.1 Shinkowa
11.1.1 Shinkowa Company Detail
11.1.2 Shinkowa Business Overview
11.1.3 Shinkowa Live-long Medicine Introduction
11.1.4 Shinkowa Revenue in Live-long Medicine Business (2017-2022)
11.1.5 Shinkowa Recent Development
11.2 Herbalmax
11.2.1 Herbalmax Company Detail
11.2.2 Herbalmax Business Overview
11.2.3 Herbalmax Live-long Medicine Introduction
11.2.4 Herbalmax Revenue in Live-long Medicine Business (2017-2022)
11.2.5 Herbalmax Recent Development
11.3 GeneHarbor (Hong Kong) Biotechnologies Limited
11.3.1 GeneHarbor (Hong Kong) Biotechnologies Limited Company Detail
11.3.2 GeneHarbor (Hong Kong) Biotechnologies Limited Business Overview
11.3.3 GeneHarbor (Hong Kong) Biotechnologies Limited Live-long Medicine Introduction
11.3.4 GeneHarbor (Hong Kong) Biotechnologies Limited Revenue in Live-long Medicine Business (2017-2022)
11.3.5 GeneHarbor (Hong Kong) Biotechnologies Limited Recent Development
11.4 Angel Yeast
11.4.1 Angel Yeast Company Detail
11.4.2 Angel Yeast Business Overview
11.4.3 Angel Yeast Live-long Medicine Introduction
11.4.4 Angel Yeast Revenue in Live-long Medicine Business (2017-2022)
11.4.5 Angel Yeast Recent Development
11.5 Xiamen Kingdomway Group Company
11.5.1 Xiamen Kingdomway Group Company Company Detail
11.5.2 Xiamen Kingdomway Group Company Business Overview
11.5.3 Xiamen Kingdomway Group Company Live-long Medicine Introduction
11.5.4 Xiamen Kingdomway Group Company Revenue in Live-long Medicine Business (2017-2022)
11.5.5 Xiamen Kingdomway Group Company Recent Development
11.6 ABACHEM
11.6.1 ABACHEM Company Detail
11.6.2 ABACHEM Business Overview
11.6.3 ABACHEM Live-long Medicine Introduction
11.6.4 ABACHEM Revenue in Live-long Medicine Business (2017-2022)
11.6.5 ABACHEM Recent Development
11.7 China Resources Double-Crane Pharmaceutical Co.,Ltd.
11.7.1 China Resources Double-Crane Pharmaceutical Co.,Ltd. Company Detail
11.7.2 China Resources Double-Crane Pharmaceutical Co.,Ltd. Business Overview
11.7.3 China Resources Double-Crane Pharmaceutical Co.,Ltd. Live-long Medicine Introduction
11.7.4 China Resources Double-Crane Pharmaceutical Co.,Ltd. Revenue in Live-long Medicine Business (2017-2022)
11.7.5 China Resources Double-Crane Pharmaceutical Co.,Ltd. Recent Development
11.8 Guangdong Zhongsheng Pharmaceutical Co.,Ltd.
11.8.1 Guangdong Zhongsheng Pharmaceutical Co.,Ltd. Company Detail
11.8.2 Guangdong Zhongsheng Pharmaceutical Co.,Ltd. Business Overview
11.8.3 Guangdong Zhongsheng Pharmaceutical Co.,Ltd. Live-long Medicine Introduction
11.8.4 Guangdong Zhongsheng Pharmaceutical Co.,Ltd. Revenue in Live-long Medicine Business (2017-2022)
11.8.5 Guangdong Zhongsheng Pharmaceutical Co.,Ltd. Recent Development
11.9 Hunan Er-Kang Pharmaceutical Co., Ltd.
11.9.1 Hunan Er-Kang Pharmaceutical Co., Ltd. Company Detail
11.9.2 Hunan Er-Kang Pharmaceutical Co., Ltd. Business Overview
11.9.3 Hunan Er-Kang Pharmaceutical Co., Ltd. Live-long Medicine Introduction
11.9.4 Hunan Er-Kang Pharmaceutical Co., Ltd. Revenue in Live-long Medicine Business (2017-2022)
11.9.5 Hunan Er-Kang Pharmaceutical Co., Ltd. Recent Development
11.10 Brotek
11.10.1 Brotek Company Detail
11.10.2 Brotek Business Overview
11.10.3 Brotek Live-long Medicine Introduction
11.10.4 Brotek Revenue in Live-long Medicine Business (2017-2022)
11.10.5 Brotek Recent Development
11.11 Xiwang Food
11.11.1 Xiwang Food Company Detail
11.11.2 Xiwang Food Business Overview
11.11.3 Xiwang Food Live-long Medicine Introduction
11.11.4 Xiwang Food Revenue in Live-long Medicine Business (2017-2022)
11.11.5 Xiwang Food Recent Development
11.12 Teyi Pharmaceutical Group Co.,Ltd.
11.12.1 Teyi Pharmaceutical Group Co.,Ltd. Company Detail
11.12.2 Teyi Pharmaceutical Group Co.,Ltd. Business Overview
11.12.3 Teyi Pharmaceutical Group Co.,Ltd. Live-long Medicine Introduction
11.12.4 Teyi Pharmaceutical Group Co.,Ltd. Revenue in Live-long Medicine Business (2017-2022)
11.12.5 Teyi Pharmaceutical Group Co.,Ltd. Recent Development
11.13 Bontac
11.13.1 Bontac Company Detail
11.13.2 Bontac Business Overview
11.13.3 Bontac Live-long Medicine Introduction
11.13.4 Bontac Revenue in Live-long Medicine Business (2017-2022)
11.13.5 Bontac Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of Tables
Table 1. Global Live-long Medicine Market Size Growth Rate by Type (US$ Million): 2017 VS 2021 VS 2028
Table 2. Key Players of Chinese Herbal Medicine
Table 3. Key Players of Western Medicine
Table 4. Global Live-long Medicine Market Size Growth by Application (US$ Million): 2017 VS 2021 VS 2028
Table 5. Global Live-long Medicine Market Size by Region (US$ Million): 2017 VS 2021 VS 2028
Table 6. Global Live-long Medicine Market Size by Region (2017-2022) & (US$ Million)
Table 7. Global Live-long Medicine Market Share by Region (2017-2022)
Table 8. Global Live-long Medicine Forecasted Market Size by Region (2023-2028) & (US$ Million)
Table 9. Global Live-long Medicine Market Share by Region (2023-2028)
Table 10. Live-long Medicine Market Trends
Table 11. Live-long Medicine Market Drivers
Table 12. Live-long Medicine Market Challenges
Table 13. Live-long Medicine Market Restraints
Table 14. Global Live-long Medicine Revenue by Players (2017-2022) & (US$ Million)
Table 15. Global Live-long Medicine Market Share by Players (2017-2022)
Table 16. Global Top Live-long Medicine Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Live-long Medicine as of 2021)
Table 17. Ranking of Global Top Live-long Medicine Companies by Revenue (US$ Million) in 2021
Table 18. Global 5 Largest Players Market Share by Live-long Medicine Revenue (CR5 and HHI) & (2017-2022)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players Live-long Medicine Product Solution and Service
Table 21. Date of Enter into Live-long Medicine Market
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Live-long Medicine Market Size by Type (2017-2022) & (US$ Million)
Table 24. Global Live-long Medicine Revenue Market Share by Type (2017-2022)
Table 25. Global Live-long Medicine Forecasted Market Size by Type (2023-2028) & (US$ Million)
Table 26. Global Live-long Medicine Revenue Market Share by Type (2023-2028)
Table 27. Global Live-long Medicine Market Size by Application (2017-2022) & (US$ Million)
Table 28. Global Live-long Medicine Revenue Market Share by Application (2017-2022)
Table 29. Global Live-long Medicine Forecasted Market Size by Application (2023-2028) & (US$ Million)
Table 30. Global Live-long Medicine Revenue Market Share by Application (2023-2028)
Table 31. North America Live-long Medicine Market Size by Country (2017-2022) & (US$ Million)
Table 32. North America Live-long Medicine Market Size by Country (2023-2028) & (US$ Million)
Table 33. Europe Live-long Medicine Market Size by Country (2017-2022) & (US$ Million)
Table 34. Europe Live-long Medicine Market Size by Country (2023-2028) & (US$ Million)
Table 35. Asia-Pacific Live-long Medicine Market Size by Region (2017-2022) & (US$ Million)
Table 36. Asia-Pacific Live-long Medicine Market Size by Region (2023-2028) & (US$ Million)
Table 37. Latin America Live-long Medicine Market Size by Country (2017-2022) & (US$ Million)
Table 38. Latin America Live-long Medicine Market Size by Country (2023-2028) & (US$ Million)
Table 39. Middle East & Africa Live-long Medicine Market Size by Country (2017-2022) & (US$ Million)
Table 40. Middle East & Africa Live-long Medicine Market Size by Country (2023-2028) & (US$ Million)
Table 41. Shinkowa Company Detail
Table 42. Shinkowa Business Overview
Table 43. Shinkowa Live-long Medicine Product
Table 44. Shinkowa Revenue in Live-long Medicine Business (2017-2022) & (US$ Million)
Table 45. Shinkowa Recent Development
Table 46. Herbalmax Company Detail
Table 47. Herbalmax Business Overview
Table 48. Herbalmax Live-long Medicine Product
Table 49. Herbalmax Revenue in Live-long Medicine Business (2017-2022) & (US$ Million)
Table 50. Herbalmax Recent Development
Table 51. GeneHarbor (Hong Kong) Biotechnologies Limited Company Detail
Table 52. GeneHarbor (Hong Kong) Biotechnologies Limited Business Overview
Table 53. GeneHarbor (Hong Kong) Biotechnologies Limited Live-long Medicine Product
Table 54. GeneHarbor (Hong Kong) Biotechnologies Limited Revenue in Live-long Medicine Business (2017-2022) & (US$ Million)
Table 55. GeneHarbor (Hong Kong) Biotechnologies Limited Recent Development
Table 56. Angel Yeast Company Detail
Table 57. Angel Yeast Business Overview
Table 58. Angel Yeast Live-long Medicine Product
Table 59. Angel Yeast Revenue in Live-long Medicine Business (2017-2022) & (US$ Million)
Table 60. Angel Yeast Recent Development
Table 61. Xiamen Kingdomway Group Company Company Detail
Table 62. Xiamen Kingdomway Group Company Business Overview
Table 63. Xiamen Kingdomway Group Company Live-long Medicine Product
Table 64. Xiamen Kingdomway Group Company Revenue in Live-long Medicine Business (2017-2022) & (US$ Million)
Table 65. Xiamen Kingdomway Group Company Recent Development
Table 66. ABACHEM Company Detail
Table 67. ABACHEM Business Overview
Table 68. ABACHEM Live-long Medicine Product
Table 69. ABACHEM Revenue in Live-long Medicine Business (2017-2022) & (US$ Million)
Table 70. ABACHEM Recent Development
Table 71. China Resources Double-Crane Pharmaceutical Co.,Ltd. Company Detail
Table 72. China Resources Double-Crane Pharmaceutical Co.,Ltd. Business Overview
Table 73. China Resources Double-Crane Pharmaceutical Co.,Ltd. Live-long Medicine Product
Table 74. China Resources Double-Crane Pharmaceutical Co.,Ltd. Revenue in Live-long Medicine Business (2017-2022) & (US$ Million)
Table 75. China Resources Double-Crane Pharmaceutical Co.,Ltd. Recent Development
Table 76. Guangdong Zhongsheng Pharmaceutical Co.,Ltd. Company Detail
Table 77. Guangdong Zhongsheng Pharmaceutical Co.,Ltd. Business Overview
Table 78. Guangdong Zhongsheng Pharmaceutical Co.,Ltd. Live-long Medicine Product
Table 79. Guangdong Zhongsheng Pharmaceutical Co.,Ltd. Revenue in Live-long Medicine Business (2017-2022) & (US$ Million)
Table 80. Guangdong Zhongsheng Pharmaceutical Co.,Ltd. Recent Development
Table 81. Hunan Er-Kang Pharmaceutical Co., Ltd. Company Detail
Table 82. Hunan Er-Kang Pharmaceutical Co., Ltd. Business Overview
Table 83. Hunan Er-Kang Pharmaceutical Co., Ltd. Live-long Medicine Product
Table 84. Hunan Er-Kang Pharmaceutical Co., Ltd. Revenue in Live-long Medicine Business (2017-2022) & (US$ Million)
Table 85. Hunan Er-Kang Pharmaceutical Co., Ltd. Recent Development
Table 86. Brotek Company Detail
Table 87. Brotek Business Overview
Table 88. Brotek Live-long Medicine Product
Table 89. Brotek Revenue in Live-long Medicine Business (2017-2022) & (US$ Million)
Table 90. Brotek Recent Development
Table 91. Xiwang Food Company Detail
Table 92. Xiwang Food Business Overview
Table 93. Xiwang Food Live-long MedicineProduct
Table 94. Xiwang Food Revenue in Live-long Medicine Business (2017-2022) & (US$ Million)
Table 95. Xiwang Food Recent Development
Table 96. Teyi Pharmaceutical Group Co.,Ltd. Company Detail
Table 97. Teyi Pharmaceutical Group Co.,Ltd. Business Overview
Table 98. Teyi Pharmaceutical Group Co.,Ltd. Live-long MedicineProduct
Table 99. Teyi Pharmaceutical Group Co.,Ltd. Revenue in Live-long Medicine Business (2017-2022) & (US$ Million)
Table 100. Teyi Pharmaceutical Group Co.,Ltd. Recent Development
Table 101. Bontac Company Detail
Table 102. Bontac Business Overview
Table 103. Bontac Live-long MedicineProduct
Table 104. Bontac Revenue in Live-long Medicine Business (2017-2022) & (US$ Million)
Table 105. Bontac Recent Development
Table 106. Research Programs/Design for This Report
Table 107. Key Data Information from Secondary Sources
Table 108. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Live-long Medicine Market Share by Type: 2021 VS 2028
Figure 2. Chinese Herbal Medicine Features
Figure 3. Western Medicine Features
Figure 4. Global Live-long Medicine Market Share by Application in 2021 & 2028
Figure 5. Young People Case Studies
Figure 6. Middle-aged People Case Studies
Figure 7. Old People Case Studies
Figure 8. Live-long Medicine Report Years Considered
Figure 9. Global Live-long Medicine Market Size (US$ Million), Year-over-Year: 2017-2028
Figure 10. Global Live-long Medicine Market Size, (US$ Million), 2017 VS 2021 VS 2028
Figure 11. Global Live-long Medicine Market Share by Region: 2021 VS 2028
Figure 12. Global Live-long Medicine Market Share by Players in 2021
Figure 13. Global Top Live-long Medicine Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Live-long Medicine as of 2021)
Figure 14. The Top 10 and 5 Players Market Share by Live-long Medicine Revenue in 2021
Figure 15. North America Live-long Medicine Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 16. North America Live-long Medicine Market Share by Country (2017-2028)
Figure 17. United States Live-long Medicine Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 18. Canada Live-long Medicine Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 19. Europe Live-long Medicine Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 20. Europe Live-long Medicine Market Share by Country (2017-2028)
Figure 21. Germany Live-long Medicine Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 22. France Live-long Medicine Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 23. U.K. Live-long Medicine Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 24. Italy Live-long Medicine Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 25. Russia Live-long Medicine Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 26. Nordic Countries Live-long Medicine Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 27. Asia-Pacific Live-long Medicine Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 28. Asia-Pacific Live-long Medicine Market Share by Region (2017-2028)
Figure 29. China Live-long Medicine Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 30. Japan Live-long Medicine Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 31. South Korea Live-long Medicine Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 32. Southeast Asia Live-long Medicine Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 33. India Live-long Medicine Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 34. Australia Live-long Medicine Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 35. Latin America Live-long Medicine Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 36. Latin America Live-long Medicine Market Share by Country (2017-2028)
Figure 37. Mexico Live-long Medicine Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 38. Brazil Live-long Medicine Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 39. Middle East & Africa Live-long Medicine Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 40. Middle East & Africa Live-long Medicine Market Share by Country (2017-2028)
Figure 41. Turkey Live-long Medicine Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 42. Saudi Arabia Live-long Medicine Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 43. Shinkowa Revenue Growth Rate in Live-long Medicine Business (2017-2022)
Figure 44. Herbalmax Revenue Growth Rate in Live-long Medicine Business (2017-2022)
Figure 45. GeneHarbor (Hong Kong) Biotechnologies Limited Revenue Growth Rate in Live-long Medicine Business (2017-2022)
Figure 46. Angel Yeast Revenue Growth Rate in Live-long Medicine Business (2017-2022)
Figure 47. Xiamen Kingdomway Group Company Revenue Growth Rate in Live-long Medicine Business (2017-2022)
Figure 48. ABACHEM Revenue Growth Rate in Live-long Medicine Business (2017-2022)
Figure 49. China Resources Double-Crane Pharmaceutical Co.,Ltd. Revenue Growth Rate in Live-long Medicine Business (2017-2022)
Figure 50. Guangdong Zhongsheng Pharmaceutical Co.,Ltd. Revenue Growth Rate in Live-long Medicine Business (2017-2022)
Figure 51. Hunan Er-Kang Pharmaceutical Co., Ltd. Revenue Growth Rate in Live-long Medicine Business (2017-2022)
Figure 52. Brotek Revenue Growth Rate in Live-long Medicine Business (2017-2022)
Figure 53. Xiwang Food Revenue Growth Rate in Live-long Medicine Business (2017-2022)
Figure 54. Teyi Pharmaceutical Group Co.,Ltd. Revenue Growth Rate in Live-long Medicine Business (2017-2022)
Figure 55. Bontac Revenue Growth Rate in Live-long Medicine Business (2017-2022)
Figure 56. Bottom-up and Top-down Approaches for This Report
Figure 57. Data Triangulation
Figure 58. Key Executives Interviewed
Industry Market Size
